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Background: An increase in cryptorchidism has been reported in many countries. One mechanism could be low
fetal testosterone production possibly secondary to altered placental human chorionic gonadotrophin (hCG)
release. Our Objective was to compare hCG values from maternal blood between boys with cryptorchidism and
normal boys.
Methods: Total hCG and α-fetoprotein (AFP) values [12–16 weeks of gestation; from the double test for Down
syndrome screening) were compared between cases of cryptorchidism and normal control boys who were
matched for maternal age, maternal smoking, gestational age at time of hCG measurement (±1 day), birth weight
and birth term. Measurements were performed in a single laboratory; values were expressed as absolute values
(KU/L) and multiples of the median (MoM). Boys whose mothers had had a complicated pregnancy were excluded.
Groups were compared using the Student’s t test. Log transformation was used to normalize hCG, MoM hCG, AFP
and MoM AFP distribution, and values were expressed as geometric means (−1, + 1 tolerance factor).
Results: Total hCG and MoM hCG levels were significantly lower in the 51 boys with cryptorchidism compared to
306 controls (21.4 (12.3; 37) KU/L vs 27.7 (15.9; 47.9) KU/L and 0.8 (0.5; 1.2) MoM vs 1.0 (0.6; 1.6) MoM, respectively,
p < 0.01). By contrast, AFP and MoM AFP levels were similar between groups.
Conclusion: This study showed a link between low maternal serum hCG levels and cryptorchidism in boys from
uncomplicated pregnancy, while normal AFP levels indicated a normal fetoplacental unit. Whether these
abnormalities were due to endogenous or exogenous factors remains to be determined.
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Several studies have reported an unexplained increase in
congenital malformations of the male reproductive tract,
such as hypospadias and cryptorchidism [1]. Only a small
proportion of hypospadias and cryptorchidism have been
linked to genetic causes, while maternal pre-eclampsia,
maternal diabetes and fetal size and premature birth were
statistically associated with such malformations and there-
fore considered risk factors [2,3].* Correspondence: recoutant@chu-angers.fr
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unless otherwise stated.As male sexual differentiation is critically dependent on
a balanced androgen to estrogen ratio, it has been postu-
lated that male genital malformations may be related to in
utero disturbances in exposure to estrogens and andro-
gens [4]. One mechanism may be low fetal testosterone
exposure, as testosterone and dihydrotestosterone are re-
sponsible for the closure of the urethal groove, the growth
of the penis and migration of the testes [4-6]. Recent ex-
perimental studies in rats have identified a programming
window for reproductive male masculinization preceding
morphological differentiation [7]: interfering with andro-
gen action during a window from E15.5 toE21.5 of rat ges-
tation led to the highest rate of cryptorchidism (aboutal Ltd. This is an Open Access article distributed under the terms of the Creative
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only (E15.5-E17.5, 30% of cryptorchidism), or a late win-
dow only (E19.5-E21.5, no cryptorchidism). Based on the
timings in rats, the programming window in humans
would be 8–14 weeks of gestation [7]. In humans, testos-
terone is produced by the testes mainly in response to pla-
cental human chorionic gonadotrophin (hCG) during the
first and second trimester of gestation , though regulation
of placental hCG is complex and poorly understood [4,5].
Exposure to high estrogen concentrations could be an-
other non exclusive mechanism [8]. Diethylstilbestrol
(DES), an estrogenic endocrine disruptor chemical (EDC)
has been shown to induce cryptorchidism in sons of
mothers who took DES [8]. Although definitive proof of a
physiological link between estrogen exposure and ab-
normal male differentiation is elusive, estrogens have
been shown to inhibit placental gonadotropin releasing
hormone (GnRH) [9], a key hormone stimulating hCG
production [10]. Finally, all these studies suggest that
abnormal placental hCG production could play a key
role in disorders of sex differentation.
The present study used samples from Down syn-
drome screening, a double test combining total hCG
and α-fetoprotein (AFP) measurements, which is offered
to pregnant women in France during the second trimes-
ter of pregnancy. We showed that total hCG values were
lower in cases of cryptorchidism in boys compared with
those from normal control boys.
Methods
Patients
Prepubertal boys born between 1/1/99 and 31/12/07, at
term (37 to 40 weeks of gestation) and presenting with
uni or bilateral cryptorchidism (undescended testes which
were not palpable in the scrotum or outside the external
ring at 6 months of age or older) and referred to the
Pediatric Surgery or Pediatric Endocrinology Units of
Angers University Hospital were included in the study if
their mothers had had blood collected at the University
Hospital of Angers for Down syndrome screening. Boys
who had also hypospadias or major anomalies of the geni-
talia were excluded from participating (since molecular
causes could be expected with a higher likelihood in these
cases). Boys whose mothers had had a complicated preg-
nancy were also excluded. The study was approved by the
Institutional Review Board of Angers University Hospital.
Affected boys were at least 6 months’ old at time of med-
ical examination. Fifty one boys had cryptorchidism, in-
cluding 3 bilateral cases, and 5 boys with associated
micropenis (as defined by a stretched penile length < 3 cm
between 1 and 12 months, and < 3.5 cm after 12 months).
Anorchia was excluded (all had detectable antimullerian
hormone concentration). In patients with bilateral cryp-
torchidism and/or associated micropenis, hypogonadotropichypogonadism was excluded by testosterone measurement
following an hCG test, as well as baseline inhibin B and
antimullerian hormone measurements. The cases were
compared with healthy boys born during the same time
period in the Department of Obstetrics of Angers Univer-
sity Hospital, whose mothers had had blood collected at
the University Hospital of Angers for double test scree-
ning (Down syndrome screening), and whose neonatal re-
cords reported no genital abnormalities: 306 controls
babies were matched for maternal age (±0.5 yrs), maternal
smoking (yes/no), gestational age at time of hCG mea-
surement (±1 day), birth weight (±100 g), and week of ges-
tation at birth ( ±1 wk) (i.e. 1 case per 6−8 controls).
Laboratory analyses
All mothers had had blood drawn between 12 and 16 weeks
of gestation, as determined from an early ultrasound scan.
Total hCG and AFP were measured by immunofluores-
cence using a commercially available kit (Autodelfia Perkin
Elmer, Wallac, Finalnd). Values were expressed as absolute
values (kilounits/L; KU/L) and multiples of the median
(MoM). hCG or AFP are expressed as MoM by dividing
the hCG or AFP concentration by the median value for the
appropriate week and day of gestation using the Multicalc
software (Wallac, Finalnd).
Statsitical analyses
Statistical analyses were performed using SPSS 16.0 soft-
ware (SPSS Inc., Chicago, Illinois, USA). Log transfor-
mation was used to normalize hCG, MoM hCG, AFP and
MoM AFP distribution, and values were expressed as geo-
metric means (the antilogarithm of the mean of the loga-
rithmically transformed data) (−1, + 1 tolerance factor)
( the antilogarithm of the standard deviation). Multiplying
or dividing the geometric mean by the tolerance factor, or
the square of the tolerance factor, is the equivalent of
adding and subtracting one or two standard deviations
in a normally distributed population. Other values were
expressed as means (±SD) and groups were compared
using the Student’s t test. Differences were considered to
be significant if P < 0.05.
Results
Characteristics of the 51 cases of cryptorchidism and their
306 matched controls are shown in Table 1. No difference
in clinical as well as biological characteristics was seen
between subjects with unilateral cryptorchidism, bilateral
cryptorchidism, or cryptorchidism associated with micro-
penis (not shown).
Total hCG and MoM hCG levels were significantly
lower in the 51 boys with cryptorchidism compared to 306
controls (21.4 (12.3; 37) KU/L vs 27.7 (15.9; 47.9) KU/L
and 0.8 (0.5; 1.2) MoM vs 1.0 (0.6; 1.6) MoM, respectively,
Table 1 Characteristics of cases with cryptorchidism and
their matched controls
Cryptorchidism Matched controls P
Number of cases (N) 51 306 NS
Birth weight (kg) 3.31 ± 0.48 3.34 ± 0.46 NS
Birth term (weeks) 39.5 ± 1.2 39.5 ± 1.3 NS
Maternal age (years) 29.9 ± 4.4 29.5 ± 4.6 NS
Gestational age at
time of screening (weeks)
13.6 ± 1.0 13.6 ± 1.0 NS
hCG (KU/L)a 21.4 (12.3; 37) 27.7 (15.9; 47.9) < 0.01
MoM hCGa 0.8 (0.5; 1.2) 1.0 (0.6; 1.6) < 0.01
AFP (KU/L)a 28.0 (18.6; 42.6) 28.8 (20.5; 40.5) NS
MoM AFPa 0.9 (0.7; 1.4) 0.9 (0.7; 1.3) NS
ageometric mean (−1, + 1 tolerance factor).
hCG human chorionic gonadotrophin, AFP α-fetoprotein, MoM multiples of
the median.
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similar between groups (Table 1).
Discussion
Our data suggest a pathophysiologic link between placen-
tal hCG production and cryptorchidism. Relative hCG in-
sufficiency could contribute to cryptorchidism, as hCG is
known to stimulate fetal testicular androgen production
with peak hCG levels at weeks 8−11 of gestation, after
which hCG levels decline to 10–15% of peak concentra-
tions from week 20 of gestation [4]. Of note, fetal cir-
culating hCG is known to follow a similar pattern as
maternal hCG, with circulating values approximately one
third to one ninth of maternal values, fetal hCG being a
more important ligand than luteinizing hormone (LH) for
stimulating steroidogenesis up to 20 weeks of gestation
[4]. The lower hCG values observed in mothers of boys
with cryptorchidism could, therefore, lead to lower fetal
testosterone production, thus contributing to the defect in
testis migration. The association between placental hCG
and minor genital anomalies has already been raised in a
few studies [11-13]. No difference [11,13], or, at most, a
trend toward a difference [12] was seen between affected
boys and controls. However, these studies were associated
with some limitations. Boys with cryptorchidism were
mixed with subjects with hypospadias, the cohorts of cases
and controls were small, serum samples were old stored
samples, and the matching of subjects and controls was
not precise, even for gestational age at time of hCG meas-
urement (important considering that maternal hCG levels
can change by up to 20% from one week to the next at this
time of gestation) [14]. Finally, gestational age was not de-
termined by early ultrasound scan in these studies,
whereas ultrasound estimation of gestational age has been
shown to significantly reduce the variance of the markers
[15]. We therefore believe that a very precise matching forgestational age is likely to be critical, and this could ex-
plain the lack of power to differentiate hCG levels between
the groups in these previous studies. In the present study,
we excluded preterm birth as well as complicated preg-
nancy, and AFP levels were similar between cases and
controls: we believe that the normal AFP levels indicated
a normal fetoplacental unit, thus suggesting that the lower
hCG values were not due to a dysfunctioning placenta. In
one study, high AFP levels and low birth weight were both
associated with cryptorchidism [16]. The authors sug-
gested that this may reflect placental dysfunction, some
aspect of which could contribute to cryptorchidism [16].
In this previous study, hCG was not measured : whether
low hCG values due to a dysfunctioning placenta could
have also contributed to cryptorchidism is therefore
unknown.
Experimental evidences in rats have identified a pro-
gramming window for reproductive male masculinization
[7], and have shown that critical androgen action and
physiological change in androgen levels did not need to
occur at the same time. From the timing in rats, the cor-
responding programming window in humans would be
8–14 weeks of gestation whereas blood samples here were
taken between gestational week 12 and 16, corresponding
to the end of this window. Although it is likely that the al-
tered hCG levels shown here could be present earlier in
gestation, our study was not designed to ascertain this
point nor directly measure androgen levels or action.
Conclusion
In conclusion, this study showed a link between low ma-
ternal serum hCG levels and cryptorchidism in boys from
uncomplicated pregnancy. Whether these abnomalities
were due to endogenous (molecular origin or genetic sus-
ceptibility) or exogenous factors (exposure to environ-
mental compounds) remains to be determined. Although
speculative, the last hypothesis suggests that it could be
crucial to evaluate further the effects of EDCs not only on
the fetal testis, but also on the placenta.
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